Utilization of Ocrelizumab within Different Treatment Strategies for Multiple Sclerosis: A 5-Year Population-Based Study

• Главные авторы: Marcello Moccia (Автор), Giuseppina Affinito (Автор), Giuseppina Marrazzo (Автор), Tiziana Ciarambino (Автор), Paolo Di Procolo (Автор), Licia Confalonieri (Автор), Antonio Carotenuto (Автор), Maria Petracca (Автор), Roberta Lanzillo (Автор), Maria Triassi (Автор), Vincenzo Brescia Morra (Автор), Raffaele Palladino (Автор)
• Формат: ‌
• Опубликовано: MDPI AG, 2024-03-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Background: We aim to provide up-to-date real-world evidence on the persistence, adherence, healthcare resource utilization, and costs of multiple sclerosis (MS) by comparing ocrelizumab to other disease-modifying treatments (DMTs) and within different DMT sequences. Methods: We included 3371 people...